New York 2023-2024 Regular Session

New York Assembly Bill A08467

Introduced
12/29/23  
Refer
12/29/23  
Refer
1/3/24  
Report Pass
2/13/24  
Engrossed
2/26/24  
Refer
2/26/24  
Engrossed
3/11/24  
Enrolled
12/12/24  
Chaptered
12/17/24  

Caption

Includes xylazine and other substances in the definition of drug adulterant testing supplies for the purposes of the dispensing of such supplies by health care professionals or pharmacists to any person.

Companion Bills

NY S07833

Same As Includes xylazine and other substances in the definition of drug adulterant testing supplies for the purposes of the dispensing of such supplies by health care professionals or pharmacists to any person.

Previously Filed As

NY S07833

Includes xylazine and other substances in the definition of drug adulterant testing supplies for the purposes of the dispensing of such supplies by health care professionals or pharmacists to any person.

NY S02099

Enacts Matthew's law which provides for the dispensing of drug adulterant testing supplies by health care professionals or pharmacists to any person.

NY A05200

Enacts Matthew's law which provides for the dispensing of drug adulterant testing supplies by health care professionals or pharmacists to any person.

NY A08217

Alters the definition of "drug" to include any substance or combination of substances that impair, to any extent, physical or mental abilities.

NY S07741

Defines "closed period of eligibility" for purposes of supplemental security income for aged, blind, and disabled persons; includes such time period in the eligibility requirements of such supplemental security income.

NY A08525

Clarifies provisions relating to dispensing of drug adulterant testing supplies.

NY S08061

Clarifies provisions relating to dispensing of drug adulterant testing supplies.

NY S07668

Prohibits the knowing sale of xylazine above a certain weight to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

NY A01248

Prohibits the knowing sale of xylazine above a certain weight to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

NY S07924

Establishes a gender affirming care fund and program to provide support and increase access to gender affirming care including medical and surgical care and therapies, equipment and supplies and mental health treatment.

Similar Bills

No similar bills found.